Additional Information about Barclays Bank PLC and the Notes
Barclays Bank PLC has filed a registration statement (including a
prospectus) with the U.S. Securities and Exchange Commission ("SEC")
for the offerings to which this free writing prospectus relates.
Before you invest, you should read the prospectus dated August 31,
2010, the prospectus supplement dated May 27, 2011 and other
documents Barclays Bank PLC has filed with the SEC for more complete
information about Barclays Bank PLC and these offerings. Buyers
should rely upon the prospectus, prospectus supplement and any
relevant free writing prospectus or pricing supplement for complete
details. You may get these documents and other documents Barclays
Bank PLC has filed for free by visiting EDGAR on the SEC website at
www.sec.gov. Alternatively, Barclays Bank PLC or any agent or dealer
participating in these offerings will arrange to send you the
prospectus, prospectus supplement, preliminary pricing supplement, if
any, and final pricing supplement (when completed) and this free
writing prospectus if you request it by calling your Barclays Bank
PLC sales representative, such dealer or 1-888-227-2275 (Extension
2-3430). A copy of the prospectus may be obtained from Barclays
Capital Inc., 745 Seventh Avenue Attn: US InvSol Support, New York,
NY 10019.
You may revoke your offer to purchase the Notes at any time prior to
the pricing as described on the cover of this free writing
prospectus. We reserve the right to change the terms of, or reject
any offer to purchase the Notes prior to their issuance. In the event
of any changes to the terms of the Notes, we will notify you and you
will be asked to accept such changes in connection with your
purchase. You may also choose to reject such changes in which case we
may reject your offer to purchase.
You should read this free writing prospectus together with the
prospectus dated August 31, 2010, as supplemented by the prospectus
supplement dated May 27, 2011 relating to our Global Medium-Term
Securities, Series A, of which these Notes are a part. This free
writing prospectus, together with the documents listed below,
contains the terms of the Notes and supersedes all prior or
contemporaneous oral statements as well as any other written
materials including preliminary or indicative pricing terms,
correspondence, trade ideas, structures for implementation, sample
structures, brochures or other educational materials of ours. You
should carefully consider, among other things, the matters set forth
in "Key Risks" herein and in "Risk Factors" in the prospectus
supplement, as the Notes involve risks not associated with
conventional debt securities. We urge you to consult your investment,
legal, tax, accounting and other advisors before you invest in
the Notes.
If the terms in the prospectus and prospectus supplement are
inconsistent with the terms discussed herein, the terms discussed in
this free writing prospectus will control.
You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings for
the relevant date on the SEC website):
Our SEC file number is 1-10257. References to "Barclays," "Barclays
Bank PLC," "we," "our" and "us" refer only to Barclays Bank PLC and
not to its consolidated subsidiaries. In this document, "Notes"
refers to the three different series of Airbag Autocallable Yield
Optimization Notes that are offered hereby, unless the context
otherwise requires.